Rankings
▼
Calendar
LTRN Q1 2020 Earnings — Lantern Pharma Inc. Revenue & Financial Results | Market Cap Arena
LTRN
Lantern Pharma Inc.
$30M
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$477,276
Net Income
-$477,276
EPS (Diluted)
$-0.08
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$703,048
Free Cash Flow
-$703,050
Stock-Based Comp.
$18,460
Balance Sheet
Total Assets
$1M
Total Liabilities
$501,526
Stockholders' Equity
$536,468
Cash & Equivalents
$634,247
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$477,276
-$453,973
-5.1%
Net Income
-$477,276
-$453,973
-5.1%
← FY 2020
All Quarters
Q2 2020 →